Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

TYO:4596 Income Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	27	39	8	-	37
Revenue Growth (YoY)	-30.77%	387.50%	-	-	-
Cost of Revenue	5	12	5	-	-
Gross Profit	22	27	3	-	37
Selling, General & Admin	711	633	602	604	607
Research & Development	543	788	1,512	2,040	1,972
Other Operating Expenses	1	110	-	-	-
Operating Expenses	1,255	1,531	2,114	2,644	2,579
Operating Income	-1,233	-1,504	-2,111	-2,644	-2,542
Interest Expense	-7	-9	-11	-18	-16
Interest & Investment Income	5	13	18	11	67
Other Non Operating Income (Expenses)	15	11	89	35	54
EBT Excluding Unusual Items	-1,220	-1,489	-2,015	-2,616	-2,437
Gain (Loss) on Sale of Assets	-56	-	-	-	-
Asset Writedown	-56	-	-	-	-
Pretax Income	-1,332	-1,489	-2,015	-2,616	-2,437
Net Income	-1,332	-1,489	-2,015	-2,616	-2,437
Net Income to Common	-1,332	-1,489	-2,015	-2,616	-2,437
Shares Outstanding (Basic)	56	56	49	46	43
Shares Outstanding (Diluted)	56	56	49	46	43
Shares Change (YoY)	1.35%	12.85%	8.19%	6.30%	2.09%
EPS (Basic)	-23.64	-26.78	-40.90	-57.45	-56.89
EPS (Diluted)	-23.65	-26.79	-40.92	-57.46	-56.90
Free Cash Flow	-1,244	-1,401	-2,143	-2,521	-2,261
Free Cash Flow Per Share	-22.08	-25.20	-43.50	-55.36	-52.78
Gross Margin	81.48%	69.23%	37.50%	-	100.00%
Operating Margin	-4566.67%	-3856.41%	-26387.50%	-	-6870.27%
Profit Margin	-4933.33%	-3817.95%	-25187.50%	-	-6586.49%
Free Cash Flow Margin	-4607.41%	-3592.31%	-26787.50%	-	-6110.81%
EBITDA	-1,168	-1,417	-2,053	-2,585	-2,497
D&A For EBITDA	65	87	58	59	45
EBIT	-1,233	-1,504	-2,111	-2,644	-2,542

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.